Company / Shares Outstanding
Xeris Biopharma Holdings, Inc. Shares Outstanding History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
149.4M
FY2025
5-year range
42.6M / 149.4M
FY2021-FY2025
Trend
+8.2%
vs FY2024
Sector context
#64 of 212
Health Care
What the data says
At 149429410.00, Xeris Biopharma Holdings, Inc.'s shares outstanding ranks #149 of 212 in the Health Care sector. Shares Outstanding has increased for 4 consecutive years, from 42642901.00 in FY2021 to 149429410.00 in FY2025.
Based on SEC 10-K filings.
149429410.00 in FY2025 with a 5-year CAGR of +28.5%.
Increased from 136273090.00 to 149429410.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +6.2%
- 5-Year CAGR
- +28.5%
- 10-Year CAGR
- -
Sector benchmark
#149 of 212 in Health CareTop 70% of 212This company 149.4M Sector average 306.7M
▼
-51.3% below sector average
Key checks
Key Insights
- Xeris Biopharma Holdings, Inc.'s shares outstanding has grown for 4 consecutive years.
- In FY2025, shares outstanding increased 8.2% year-over-year.
- Ranks #64 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.26 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 149.4M | +8.2% |
| FY2024 | 138.1M | +1.4% |
| FY2023 | 136.3M | +9.1% |
| FY2022 | 124.9M | +192.8% |
| FY2021 | 42.6M | +0.0% |
| FY2020 | 42.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026